CN113461578B - Green synthesis method of functionalized sulfoxide compound - Google Patents
Green synthesis method of functionalized sulfoxide compound Download PDFInfo
- Publication number
- CN113461578B CN113461578B CN202110909137.9A CN202110909137A CN113461578B CN 113461578 B CN113461578 B CN 113461578B CN 202110909137 A CN202110909137 A CN 202110909137A CN 113461578 B CN113461578 B CN 113461578B
- Authority
- CN
- China
- Prior art keywords
- functionalized
- reaction
- synthesis method
- phenyl
- sulfinic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 sulfoxide compound Chemical class 0.000 title claims abstract description 31
- 238000001308 synthesis method Methods 0.000 title claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- 238000004440 column chromatography Methods 0.000 claims abstract description 11
- 239000012074 organic phase Substances 0.000 claims abstract description 10
- AHZJKOKFZJYCLG-UHFFFAOYSA-K trifluoromethanesulfonate;ytterbium(3+) Chemical compound [Yb+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F AHZJKOKFZJYCLG-UHFFFAOYSA-K 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 3
- 238000001035 drying Methods 0.000 claims abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 150000003462 sulfoxides Chemical class 0.000 claims description 8
- 239000003208 petroleum Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- SEEUPVOHHNMWEG-UHFFFAOYSA-N 4-fluorobenzenesulfinic acid Chemical compound OS(=O)C1=CC=C(F)C=C1 SEEUPVOHHNMWEG-UHFFFAOYSA-N 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- AUPDIWFBUOVUGO-UHFFFAOYSA-N thiophene-2-sulfinic acid Chemical compound OS(=O)C1=CC=CS1 AUPDIWFBUOVUGO-UHFFFAOYSA-N 0.000 claims description 3
- 238000000967 suction filtration Methods 0.000 claims description 2
- NKTDTMONXHODTI-UHFFFAOYSA-N 2-pentyne Chemical compound CCC#CC NKTDTMONXHODTI-UHFFFAOYSA-N 0.000 claims 1
- FXJVNINSOKCNJP-UHFFFAOYSA-N 4-methylbenzenesulfinic acid Chemical compound CC1=CC=C(S(O)=O)C=C1 FXJVNINSOKCNJP-UHFFFAOYSA-N 0.000 claims 1
- 239000003463 adsorbent Substances 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 11
- 239000002253 acid Substances 0.000 abstract description 8
- 125000000524 functional group Chemical group 0.000 abstract description 6
- 230000035484 reaction time Effects 0.000 abstract description 5
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- HVVZVBWIBBTXAJ-UHFFFAOYSA-N 1-methylideneindene Chemical compound C1=CC=C2C(=C)C=CC2=C1 HVVZVBWIBBTXAJ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 3
- PSWDQTMAUUQILQ-UHFFFAOYSA-N 2-[(6-methoxy-4-methylquinazolin-2-yl)amino]-5,6-dimethyl-1h-pyrimidin-4-one Chemical compound N1=C(C)C2=CC(OC)=CC=C2N=C1NC1=NC(=O)C(C)=C(C)N1 PSWDQTMAUUQILQ-UHFFFAOYSA-N 0.000 description 3
- OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 3
- 229940125796 compound 3d Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000000654 additive Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 description 1
- DILXLMRYFWFBGR-UHFFFAOYSA-N 2-formylbenzene-1,4-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(S(O)(=O)=O)C(C=O)=C1 DILXLMRYFWFBGR-UHFFFAOYSA-N 0.000 description 1
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000016588 Idiopathic hypersomnia Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical group C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- CDTRJYSYYSRJIL-UHFFFAOYSA-N indene Chemical group C1=CC=C2C=C=CC2=C1 CDTRJYSYYSRJIL-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001165 modafinil Drugs 0.000 description 1
- 201000003631 narcolepsy Diseases 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000012005 post-metallocene catalyst Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
- 125000003375 sulfoxide group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/06—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种亚砜类化合物的合成方法,尤其涉及一种苯并富烯官能化的亚砜类化合物的绿色合成方法。The invention relates to a synthesis method of sulfoxide compounds, in particular to a green synthesis method of benzofulvene-functionalized sulfoxide compounds.
背景技术Background technique
亚砜基是一种具有重要价值的含硫官能团,广泛存在于天然产物和临床治疗药物中,如市售用于治疗胃溃疡和反流性食管炎的药物奥美拉唑,以及用于治疗抑郁症、特发性嗜睡或发作性睡眠症的莫达非尼。此外,苯并富烯是一类具有环外碳-碳双键的苯并环戊二烯骨架的分子。苯并富烯不仅是许多药物分子和天然产物的核心结构骨架,同时也是一类重要的合成中间体。近年来,苯并富烯也被应用于高分子功能材料研究中,通过改变官能团可以改变聚合物材料的性质,在光电材料方面有着广阔的应用前景。此外,苯并富烯及其衍生物含有一个环戊二烯的骨架, 可用于制备后茂金属催化剂,应用于应用于不对称的烯烃聚合反应、Diels-Alder反应等有机合成中。基于苯并富烯官能化的亚砜类化合物在药物化学和合成化学等方面的重要作用,可以大胆预测苯并富烯官能化的亚砜类化合物将可能具有潜在的十分重要的应用价值。然而,目前,还没有有效的方法合成苯并富烯官能化的亚砜类化合物。因此, 探索绿色、简便、条件温和的合成苯并富烯官能化的亚砜类化合物的新方法在医药化学、合成化学和材料科学等领域中具有重要意义。The sulfoxide group is a sulfur-containing functional group of great value, which widely exists in natural products and clinical therapeutic drugs, such as the commercially available drug omeprazole for the treatment of gastric ulcer and reflux esophagitis, as well as for the treatment of Modafinil for depression, idiopathic hypersomnia, or narcolepsy. In addition, benzofulvenes are a class of molecules having a benzocyclopentadiene skeleton with exocyclic carbon-carbon double bonds. Benzofulvene is not only the core structure skeleton of many drug molecules and natural products, but also an important class of synthetic intermediates. In recent years, benzofulvene has also been used in the research of polymer functional materials. By changing the functional groups, the properties of polymer materials can be changed, and it has broad application prospects in optoelectronic materials. In addition, benzofulvene and its derivatives contain a cyclopentadiene skeleton, which can be used to prepare post-metallocene catalysts and be applied to organic synthesis such as asymmetric olefin polymerization and Diels-Alder reaction. Based on the important role of benzofulvene-functionalized sulfoxide compounds in medicinal chemistry and synthetic chemistry, it can be boldly predicted that benzofulvene-functionalized sulfoxide compounds may have potentially very important application values. However, at present, there is no efficient method for the synthesis of benzofulvene-functionalized sulfoxides. Therefore, it is of great significance to explore new methods for the synthesis of benzofulvene-functionalized sulfoxides that are green, simple, and mild in conditions, in the fields of medicinal chemistry, synthetic chemistry, and materials science.
发明内容Contents of the invention
为了弥补现有技术中存在的不足,本发明的目的在于提供一种简单和绿色的方法实现苯并富烯官能化的亚砜类化合物的合成,在水相反应中、以廉价易得的芳基亚磺酸和1,3-烯炔为原料,该反应具有操作简单,反应时间短,条件绿色、温和,产物易分离,官能团兼容性较好等优点。In order to make up for the deficiencies in the prior art, the object of the present invention is to provide a simple and green method to realize the synthesis of benzofulvene-functionalized sulfoxide compounds. Using sulfinic acid and 1,3-enyne as raw materials, the reaction has the advantages of simple operation, short reaction time, green and mild conditions, easy separation of products, and good functional group compatibility.
为实现上述目的,本发明所采取的技术手段是,一种苯并富烯官能化的亚砜类化合物的绿色合成方法,其步骤如下:In order to achieve the above object, the technical means adopted in the present invention is a green synthesis method of a benzofulvene-functionalized sulfoxide compound, the steps of which are as follows:
步骤一、取芳基亚磺酸,1,3-烯炔,三氟甲磺酸镱,加入盛有水溶液的反应容器中;
步骤二、将步骤一中的反应容器放在搅拌器上,室温条件下,搅拌反应若干时间;
步骤三、反应结束后,将反应混合液倒入盛有去离子水的分液漏斗中,乙酸乙酯萃取洗涤三次,合并有机相;
步骤四、将步骤三中得到的有机相用硫酸镁干燥,抽滤、除去硫酸镁,有机相用旋转蒸发仪浓缩,得到残留物;
步骤五、残留物用柱层析分离,得到目标产物功能化的亚砜类化合物。Step 5, the residue is separated by column chromatography to obtain the functionalized sulfoxide compound of the target product.
进一步的,所述步骤一中,芳基亚磺酸,1,3-烯炔,三氟甲磺酸镱称取的质量比为1:0.8~1.4:0.1~0.5。Further, in the first step, the mass ratio of arylsulfinic acid, 1,3-enyne, and ytterbium trifluoromethanesulfonate is 1:0.8-1.4:0.1-0.5.
进一步的,所述步骤二中,搅拌反应时间25~35分钟。Further, in the second step, the stirring reaction time is 25-35 minutes.
进一步的,所述步骤五中用柱层析分离是指硅胶和流动相,其中流动相为石油醚和乙酸乙酯按5:1的体积比构成。Further, the separation by column chromatography in the step five refers to silica gel and mobile phase, wherein the mobile phase is composed of petroleum ether and ethyl acetate in a volume ratio of 5:1.
进一步的,所述步骤一中,芳基亚磺酸是指:苯亚磺酸,对氟苯亚磺酸,2-噻吩亚磺酸,对甲基苯亚磺酸的一种。Further, in the first step, arylsulfinic acid refers to one of benzenesulfinic acid, p-fluorobenzenesulfinic acid, 2-thiophenesulfinic acid and p-toluenesulfinic acid.
进一步的,所述步骤一中,1,3烯炔是指:(E)-(3-苄基-2-烯-4-炔-1,2,5-苯基烯炔),(E)-(3-苄基-2-烯-4-炔-1,2,5-苯基烯炔),(E)-(3-苄基-2-烯-4-炔-1,2,5-苯基戊烯炔),(E)-4,4’-(3-苄基-5-苯基-3-烯-1-炔-1,4-二对氟苯基-1,3-戊烯炔),(E)-4,4’-(2-苯基-3-(苯基乙基)丁-2-烯-1,4-二基)双((三氟甲基)苯)的一种。Further, in the first step, 1,3 enyne refers to: ( E )-(3-benzyl-2-en-4-yne-1,2,5-phenylenyne), ( E ) -(3-Benzyl-2-en-4-yne-1,2,5-phenylenyne), ( E )-(3-benzyl-2-en-4-yne-1,2,5 -phenylpentenyne), ( E )-4,4'-(3-benzyl-5-phenyl-3-en-1-yne-1,4-di-p-fluorophenyl-1,3- pentenyne), ( E )-4,4'-(2-phenyl-3-(phenylethyl)but-2-ene-1,4-diyl)bis((trifluoromethyl)benzene ) of a kind.
进一步的,所述步骤五中,功能化的亚砜类化合物是指:(E)-2,3-二苄基-1-(苯基(苯亚磺酰基))亚甲基- 1H-茚,(E)-2,3-二苄基-1-(苯基(对氟代苯亚磺酰基))亚甲基-1H-茚, (E)-2,3-二苄基-1-(苯基(2-噻吩亚磺酰基))亚甲基- 1H-茚,(E)-2,3-二苄基-6-氟-1-(4-氟苯基(对甲基苯亚磺酰基))亚甲基- 1H-茚,(E)- 1-(苯基(对甲基苯亚磺酰基))亚甲基-2,3-二((4-三氟甲基)苄基)- 1H-茚。Further, in the step five, the functionalized sulfoxide compound refers to: (E )-2,3-dibenzyl-1-(phenyl(phenylsulfinyl))methylene- 1H- Indene, ( E )-2,3-dibenzyl-1-(phenyl(p-fluorophenylsulfinyl))methylene- 1H -indene, ( E )-2,3-dibenzyl- 1-(Phenyl(2-thiophenesulfinyl))methylene-1 H -indene, ( E )-2,3-dibenzyl-6-fluoro-1-(4-fluorophenyl(p-methyl phenylsulfinyl))methylene- 1H -indene, ( E )-1-(phenyl(p-methylphenylsulfinyl))methylene-2,3-bis((4-trifluoro methyl)benzyl) -1H -indene.
本发明的有益效果是:采用绿色、简单、有效、无外加添加剂的策略,实现了三氟甲磺酸镱催化的芳基亚磺酸与1,3-烯炔的加成环化反应,得到了新颖的苯并富烯官能化的亚砜类化合物;该反应以廉价易得芳基亚磺酸和1,3-烯炔为反应原料,具有操作简单,反应时间短,条件绿色、温和,产物易分离,官能团兼容性较好等优点,为苯并富烯官能化的亚砜类化合物在医药化学和材料科学等领域进一步的应用奠定基础。The beneficial effect of the present invention is: the addition and cyclization reaction of arylsulfinic acid and 1,3-enyne catalyzed by ytterbium trifluoromethanesulfonate is realized by adopting a green, simple, effective, and no external additive strategy, and the obtained A novel sulfoxide compound functionalized with benzofulvene was developed; the reaction uses cheap and easily available arylsulfinic acid and 1,3-enyne as the reaction raw materials, and has the advantages of simple operation, short reaction time, green and mild conditions, The advantages of easy separation of products and good functional group compatibility lay the foundation for the further application of benzofulvene-functionalized sulfoxide compounds in the fields of medicinal chemistry and material science.
附图说明Description of drawings
下面结合视图和实施例对本发明做详细的描述。The present invention will be described in detail below in conjunction with drawings and embodiments.
图1本发明的化学反应方程式;Fig. 1 chemical reaction equation of the present invention;
图2本发明实施例1的化合物3a的氢谱图;The hydrogen spectrogram of the
图3本发明实施例1的化合物3a的碳谱图;The carbon spectrogram of the
图4本发明实施例2的化合物3b的氢谱图;The hydrogen spectrogram of the
图5本发明实施例2的化合物3b的碳谱图;The carbon spectrogram of the
图6本发明实施例3的化合物3c的氢谱图;The hydrogen spectrogram of the
图7本发明实施例3的化合物3c的碳谱图;The carbon spectrogram of
图8本发明实施例4的化合物3d的氢谱图;The hydrogen spectrogram of the
图9本发明实施例4的化合物3d的碳谱图;The carbon spectrogram of the
图10 本发明实施例5的化合物3e的氢谱图;The hydrogen spectrogram of the
图11 本发明实施例5的化合物3e的碳谱图;Figure 11 is the carbon spectrum of
图12本发明实施例的得率对照表。Fig. 12 is the yield comparison table of the embodiment of the present invention.
具体实施方式Detailed ways
实施例1Example 1
如图1所示的功能化的亚砜化合物的绿色合成方法,该方法包括以下步骤:The green synthetic method of the functionalized sulfoxide compound as shown in Figure 1, the method comprises the following steps:
(1) 准确称取:71.0 mg苯亚磺酸(1a),96.0 mg 1,3-烯炔(2a),31.0 mg三氟甲磺酸镱,然后加入盛有水的反应管中;(1) Accurately weigh: 71.0 mg benzenesulfinic acid (1a), 96.0
(2) 将步骤(1)中的反应管放在磁力搅拌器上,室温条件下,搅拌反应30分钟;(2) Place the reaction tube in step (1) on a magnetic stirrer, and stir for 30 minutes at room temperature;
(3) 反应结束后,将反应混合液倒入盛有10.0 mL去离子水的分液漏斗中,乙酸乙酯萃取洗涤三次,每次5.0 mL,合并有机相;(3) After the reaction, pour the reaction mixture into a separatory funnel filled with 10.0 mL of deionized water, extract and wash with ethyl acetate three times, 5.0 mL each time, and combine the organic phases;
(4) 将步骤(3)中得到的有机相用硫酸镁干燥,抽滤、除去硫酸镁,有机相用旋转蒸发仪浓缩,得到残留物;(4) the organic phase obtained in the step (3) is dried with magnesium sulfate, suction filtration, removes magnesium sulfate, and the organic phase is concentrated with a rotary evaporator to obtain a residue;
(5) 残留物用柱层析分离(硅胶,流动相:石油醚/乙酸乙酯=5:1),得到101.3 mg目标产物苯并富烯官能化的亚砜类化合物(3a)为黄色固体,产率:80%,得到的目标产物粗产品易于通过柱层析分离。(5) The residue was separated by column chromatography (silica gel, mobile phase: petroleum ether/ethyl acetate=5:1), and 101.3 mg of the target product benzofulvene-functionalized sulfoxide compound (3a) was obtained as a yellow solid , Yield: 80%, the obtained target product crude product is easy to separate by column chromatography.
如图2、3所示,化合物3a表征如下:As shown in Figures 2 and 3,
1H NMR (600 MHz, CDCl3) δ: 7.42 (t, J = 7.5 Hz, 1H), 7.37 (d, J = 7.8Hz, 1H), 7.33–7.30 (m, 5H), 7.28 (d, J = 4.2 Hz, 4H), 7.25–7.24 (m, 1H), 7.21(t, J = 6.9 Hz, 2H), 7.09–7.05 (m, 4H), 6.92 (t, J = 7.5 Hz, 1H), 6.67 (t, J= 7.5 Hz, 1H), 6.40 (d, J = 7.8 Hz, 2H), 5.91 (d, J = 7.8 Hz, 1H), 5.80 (d, J= 7.8 Hz, 1H), 4.67 (d, J = 17.4 Hz, 1H), 4.53 (d, J = 17.4 Hz, 1H), 4.12 (d,J = 15.6 Hz, 1H), 4.05 (d, J = 15.6 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ:147.9, 145.0, 143.5, 143.1, 140.8, 139.6, 137.9, 136.4, 134.0, 131.2, 130.7,130.1, 129.2, 129.0, 128.8, 128.7, 128.5, 128.3, 128.1, 128.0, 127.3, 126.5,126.4, 125.8, 124.9, 124.6, 119.6, 34.0, 31.5; HRMS (ESI) m/z: [M+H]+ calcdfor C36H29OS+ 509.1934, found 509.1931. 1 H NMR (600 MHz, CDCl 3 ) δ: 7.42 (t, J = 7.5 Hz, 1H), 7.37 (d, J = 7.8Hz, 1H), 7.33–7.30 (m, 5H), 7.28 (d, J = 4.2 Hz, 4H), 7.25–7.24 (m, 1H), 7.21(t, J = 6.9 Hz, 2H), 7.09–7.05 (m, 4H), 6.92 (t, J = 7.5 Hz, 1H), 6.67 (t, J = 7.5 Hz, 1H), 6.40 (d, J = 7.8 Hz, 2H), 5.91 (d, J = 7.8 Hz, 1H), 5.80 (d, J = 7.8 Hz, 1H), 4.67 (d , J = 17.4 Hz, 1H), 4.53 (d, J = 17.4 Hz, 1H), 4.12 (d, J = 15.6 Hz, 1H), 4.05 (d, J = 15.6 Hz, 1H); 13 C NMR (150 MHz, CDCL 3 ) Δ: 147.9, 145.0, 143.5, 143.1, 140.8, 137.9, 136.4, 134.0, 131.2, 130.7,130.1, 129.2, 128.8, 128.5, 128.3, 128.0, 127.3, 126.5 ,126.4, 125.8, 124.9, 124.6, 119.6, 34.0, 31.5; HRMS (ESI) m/z: [M+H] + calcdfor C 36 H 29 OS + 509.1934, found 509.1931.
实施例2Example 2
与实施例1制备方法中不同之处在于,改变反应原料1a为对氟苯亚磺酸(1b),并调整添加量,其他条件和实施例1相同;柱层析分离(硅胶,流动相:石油醚/乙酸乙酯(3:1)),得到目标产物3b(产率:71%)为黄色固体。The difference from the preparation method in Example 1 is that the reaction
如图4、5所示,化合物3b表征如下:As shown in Figures 4 and 5,
1H NMR (600 MHz, CDCl3) δ: 7.44 (t, J = 7.5 Hz, 1H), 7.37 (d, J = 7.8Hz, 1H), 7.34–7.26 (m, 10H), 7.23–7.19 (m, 1H), 7.10–7.06 (m, 2H), 6.97 (t, J= 7.5 Hz, 1H), 6.73 (t, J = 8.7 Hz, 2H), 6.69–6.67 (m, 1H), 6.27–6.24 (m,2H), 5.94 (d, J = 7.8 Hz, 1H), 5.82 (d, J = 7.8 Hz, 1H), 4.66 (d, J = 17.4Hz, 1H), 4.52 (d, J = 17.4 Hz, 1H), 4.12 (d, J = 15.6 Hz, 1H), 4.05 (d, J =15.6 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ: 163.8 (d, J = 249.2 Hz), 148.1,144.5, 143.5, 143.2, 139.7, 137.9, 136.3, 136.09, 136.08, 133.8, 131.1,130.5, 129.4, 129.1, 128.9, 128.7, 128.6, 128.3, 128.1, 127.4, 126.8 (d, J =8.6 Hz), 126.5 (d, J = 10.8 Hz), 125.8, 124.9, 119.7, 115.3 (d, J = 22.4 Hz),34.0, 31.5; HRMS (ESI) m/z: [M+H]+ calcd for C36H28FOS+ 539.2039, found539.2038. 1 H NMR (600 MHz, CDCl 3 ) δ: 7.44 (t, J = 7.5 Hz, 1H), 7.37 (d, J = 7.8Hz, 1H), 7.34–7.26 (m, 10H), 7.23–7.19 (m , 1H), 7.10–7.06 (m, 2H), 6.97 (t, J = 7.5 Hz, 1H), 6.73 (t, J = 8.7 Hz, 2H), 6.69–6.67 (m, 1H), 6.27–6.24 ( m,2H), 5.94 (d, J = 7.8 Hz, 1H), 5.82 (d, J = 7.8 Hz, 1H), 4.66 (d, J = 17.4Hz, 1H), 4.52 (d, J = 17.4 Hz, 1H), 4.12 (d, J = 15.6 Hz, 1H), 4.05 (d, J =15.6 Hz, 1H); 13 C NMR (150 MHz, CDCl 3 ) δ: 163.8 (d, J = 249.2 Hz), 148.1 , 144.5, 143.5, 143.2, 139.7, 137.9, 136.3, 136.09, 136.08, 133.8, 131.1.130.5, 129.4, 129.1, 128.7, 128.3, 128.1, 126.8 (D, J = 8.6 Hz), 126.5) (d, J = 10.8 Hz), 125.8, 124.9, 119.7, 115.3 (d, J = 22.4 Hz), 34.0, 31.5; HRMS (ESI) m/z: [M+H] + calcd for C 36 H 28 FOS +539.2039 , found539.2038.
实施例3Example 3
与实施例1制备方法中不同之处在于,改变反应原料1a为2-噻吩亚磺酸(1c),并调整添加量,其他条件和实施例1相同。柱层析分离(硅胶,流动相:石油醚/乙酸乙酯(5:1)),得到目标产物3c(产率:88%)为黄色固体。The difference from the preparation method in Example 1 is that the reaction
如图6、7所示,化合物3c表征如下:As shown in Figures 6 and 7,
1H NMR (600 MHz, CDCl3) δ: 7.49–7.45 (m, 2H), 7.39 (t, J = 6.9 Hz,1H), 7.32 (t, J = 7.5 Hz, 2H), 7.28–7.24 (m, 8H), 7.18–7.16 (m, 1H), 7.09–7.03 (m, 3H), 6.76 (t, J = 4.2 Hz, 1H), 6.69–6.67 (m, 1H), 6.30 (d, J = 7.8Hz, 1H), 5.95 (d, J = 3.6 Hz, 1H), 5.89 (d, J = 7.8 Hz, 1H), 4.60 (d, J =17.4 Hz, 1H), 4.45 (d, J = 17.4 Hz, 1H), 4.05 (d, J = 15.6 Hz, 1H), 4.00 (d,J = 16.2 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ: 148.0, 145.3, 143.7, 143.5,142.4, 139.5, 137.8, 136.3, 133.5, 131.0, 130.6, 130.4, 129.5, 129.0, 128.82,128.78, 128.6, 128.5, 128.17, 128.15, 127.64, 127.63, 127.0, 126.4, 126.3,125.8, 124.9, 119.6, 34.1, 31.4; HRMS (ESI) m/z: [M+H]+ calcd for C34H27OS2 +515.1498, found 515.1497. 1 H NMR (600 MHz, CDCl 3 ) δ: 7.49–7.45 (m, 2H), 7.39 (t, J = 6.9 Hz,1H), 7.32 (t, J = 7.5 Hz, 2H), 7.28–7.24 (m , 8H), 7.18–7.16 (m, 1H), 7.09–7.03 (m, 3H), 6.76 (t, J = 4.2 Hz, 1H), 6.69–6.67 (m, 1H), 6.30 (d, J = 7.8 Hz, 1H), 5.95 (d, J = 3.6 Hz, 1H), 5.89 (d, J = 7.8 Hz, 1H), 4.60 (d, J =17.4 Hz, 1H), 4.45 (d, J = 17.4 Hz, 1H), 4.05 (d, J = 15.6 Hz, 1H), 4.00 (d, J = 16.2 Hz, 1H); 13 C NMR (150 MHz, CDCl 3 ) δ: 148.0, 145.3, 143.7, 143.5, 142.4, 139.5 , 137.8, 136.3, 133.5, 131.0, 130.6, 130.4, 129.5, 129.0, 128.82,128.78, 128.5, 128.17, 127.64, 127.0, 126.3,125.8, 119.6, 31.4.4. (ESI) m/z: [M+H] + calcd for C 34 H 27 OS 2 + 515.1498, found 515.1497.
实施例4Example 4
与实施例1制备方法中不同之处在于,改变反应原料1a为对甲基本亚磺酸(1d),并调整添加量,原料2a调整为2b,并调整添加量,其他条件和实施例1相同。The difference from the preparation method in Example 1 is that the reaction
柱层析分离(硅胶,流动相:石油醚/乙酸乙酯(5:1)),得到目标产物(3d)为黄色固体, 产率:85%。Separation by column chromatography (silica gel, mobile phase: petroleum ether/ethyl acetate (5:1)), the target product (3d) was obtained as a yellow solid, yield: 85%.
如图8、9所示,化合物3d表征如下:As shown in Figures 8 and 9,
1H NMR (600 MHz, CDCl3) δ: 7.36–7.31 (m, 3H), 7.29–7.24 (m, 7H), 7.20–7.18 (m, 1H), 7.15–7.12 (m, 1H), 6.98–6.96 (m, 1H), 6.90 (d, J = 7.8 Hz, 2H),6.74 (t, J = 8.4 Hz, 1H), 6.70–6.67 (m, 1H), 6.26 (d, J = 7.8 Hz, 2H), 5.93–5.91 (m, 1H), 5.55 (d, J = 10.2 Hz, 1H), 4.64 (d, J = 17.4 Hz, 1H), 4.50 (d,J = 16.8 Hz, 1H), 4.09 (d, J = 15.6 Hz, 1H), 4.00 (d, J = 15.6 Hz, 1H), 2.24(s, 3H); 13C NMR (150 MHz, CDCl3) δ: 163.0 (d, J = 247.8 Hz), 161.2 (d, J =242.4 Hz), 147.3, 145.2, 142.2, 140.7, 139.30, 139.26, 139.25, 138.2, 138.1,137.5, 137.0, 133.69, 133.67, 132.8 (d, J = 8.1 Hz), 131.0 (d, J = 8.1 Hz),128.9, 128.8, 128.6, 128.1, 126.25 (d, J = 77.1 Hz), 126.17 (d, J = 60.6 Hz),124.4, 120.2, 120.1, 115.2 (d, J = 21.3 Hz), 115.0 (d, J = 22.7 Hz), 114.8,114.6, 113.0, 112.9, 33.9, 31.5, 21.1; HRMS (ESI) m/z: [M+H]+ calcd forC37H29F2OS+ 559.1902, found 559.1899. 1 H NMR (600 MHz, CDCl 3 ) δ: 7.36–7.31 (m, 3H), 7.29–7.24 (m, 7H), 7.20–7.18 (m, 1H), 7.15–7.12 (m, 1H), 6.98– 6.96 (m, 1H), 6.90 (d, J = 7.8 Hz, 2H), 6.74 (t, J = 8.4 Hz, 1H), 6.70–6.67 (m, 1H), 6.26 (d, J = 7.8 Hz, 2H ), 5.93–5.91 (m, 1H), 5.55 (d, J = 10.2 Hz, 1H), 4.64 (d, J = 17.4 Hz, 1H), 4.50 (d, J = 16.8 Hz, 1H), 4.09 (d , J = 15.6 Hz, 1H), 4.00 (d, J = 15.6 Hz, 1H), 2.24(s, 3H); 13 C NMR (150 MHz, CDCl 3 ) δ: 163.0 (d, J = 247.8 Hz), 161.2 (d, J =242.4 Hz), 147.3, 145.2, 142.2, 140.7, 139.30, 139.26, 139.25, 138.2, 138.1, 137.5, 137.0, 133.69, 133.67, 132.8, 132.8 ( d1, J = Hz) J = 8.1 Hz), 128.9, 128.8, 128.6, 128.1, 126.25 (d, J = 77.1 Hz), 126.17 (d, J = 60.6 Hz), 124.4, 120.2, 120.1, 115.2 (d, J = 21.3 Hz), 115.0 (d, J = 22.7 Hz), 114.8, 114.6, 113.0, 112.9, 33.9, 31.5, 21.1; HRMS (ESI) m/z: [M+H] + calcd for C 37 H 29 F 2 OS + 559.1902, found 559.1899.
实施例5Example 5
与实施例1制备方法中不同之处在于,改变反应原料1a为对甲基本亚磺酸(1d),并调整添加量,原料2a调整为2c,并调整添加量,其他条件和实施例1相同。The difference from the preparation method in Example 1 is that the reaction
柱层析分离(硅胶,流动相:石油醚/乙酸乙酯(5:1)),得到目标产物3e(产率:75%)为黄色固体。Column chromatography (silica gel, mobile phase: petroleum ether/ethyl acetate (5:1)) gave the
如图10、11所示,化合物3e表征如下:As shown in Figures 10 and 11,
1H NMR (600 MHz, CDCl3) δ: 7.57 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 7.8Hz, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.39–7.33 (m, 6H), 7.11 (t, J = 7.5 Hz,1H), 7.08 (d, J = 6.6 Hz, 1H), 6.98 (t, J = 7.8 Hz, 1H), 6.90 (d, J = 7.8 Hz,2H), 6.73 (t, J = 7.5 Hz, 1H), 6.28 (d, J = 7.8 Hz, 2H), 6.00 (d, J = 7.8 Hz,1H), 5.86 (d, J = 8.4 Hz, 1H), 4.73 (d, J = 18.0 Hz, 1H), 4.54 (d, J = 17.4Hz, 1H), 4.15 (d, J = 16.2 Hz, 1H), 4.11 (d, J = 16.2 Hz, 1H), 2.26 (s, 3H);13C NMR (150 MHz, CDCl3) δ: 147.2, 146.1, 143.7, 142.9, 142.5, 141.9, 140.9,137.0, 136.3, 133.5, 131.0, 130.5, 129.2, 129.014, 129.013 (q, J = 32.3 Hz),129.00, 128.97 (q, J = 32.3 Hz), 128.7, 128.5, 128.1, 127.5, 126.3, 125.70,125.67, 125.65, 125.62, 125.2, 124.3, 124.13 (q, J = 270.5 Hz), 124.06 (q, J= 270.4 Hz), 119.5, 34.1, 31.3, 21.2; HRMS (ESI) m/z: [M+H]+ calcd forC39H29F6OS+ 659.1838, found 659.1839. 1 H NMR (600 MHz, CDCl 3 ) δ: 7.57 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 7.8Hz, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.39– 7.33 (m, 6H), 7.11 (t, J = 7.5 Hz, 1H), 7.08 (d, J = 6.6 Hz, 1H), 6.98 (t, J = 7.8 Hz, 1H), 6.90 (d, J = 7.8 Hz,2H), 6.73 (t, J = 7.5 Hz, 1H), 6.28 (d, J = 7.8 Hz, 2H), 6.00 (d, J = 7.8 Hz,1H), 5.86 (d, J = 8.4 Hz, 1H), 4.73 (d, J = 18.0 Hz, 1H), 4.54 (d, J = 17.4Hz, 1H), 4.15 (d, J = 16.2 Hz, 1H), 4.11 (d, J = 16.2 Hz, 1H) , 2.26 (s, 3H); 13 C NMR (150 MHz, CDCl 3 ) δ: 147.2, 146.1, 143.7, 142.9, 142.5, 141.9, 140.9,137.0, 136.3, 133.5, 131.0, 130.5, 129.3 ( q, J = 32.3 Hz), 129.00, 128.97 (q, J = 32.3 Hz), 128.7, 128.5, 128.1, 127.5, 126.3, 125.70, 125.67, 125.65, 125.62, 125.2, 124.3 , 20 J. ), 124.06 (q, J = 270.4 Hz), 119.5, 34.1, 31.3, 21.2; HRMS (ESI) m/z: [M+H] + calcd forC 39 H 29 F 6 OS + 659.1838, found 659.1839.
以上实施例只是我们列举的部分实施例,用于验证该方法对不同反应底物的适用性,该方法可以实现含有不同取代基的芳基亚磺酸与1,3-烯炔反应,得到含有不同官能团的苯并富烯官能化的亚砜类化合物。The above examples are only some of the examples we listed to verify the applicability of this method to different reaction substrates. This method can realize the reaction of arylsulfinic acid containing different substituents with 1,3-enyne to obtain Benzofulvene-functionalized sulfoxides with different functional groups.
实施例的产率对比表如图12所示,由于不同取代基的影响,所得到的目标产物的产率有所不同。The yield comparison table of the examples is shown in Figure 12. Due to the influence of different substituents, the yields of the obtained target products are different.
从上述实施例中不难看出,本发明具有以下优点:It is not difficult to find out from the foregoing embodiments that the present invention has the following advantages:
1.首次实现了苯并富烯官能化的亚砜类化合物的绿色合成。1. The green synthesis of benzofulvene-functionalized sulfoxide compounds was realized for the first time.
2.采用简单、温和和绿色的方法实现了含有不同取代基(甲基、氟、三氟甲基)的苯并富烯官能化的亚砜类化合物的制备,以水为反应溶剂,无需其它外加的添加物,得到了新颖的功能化的亚砜类化合物,该类化合通过核磁、高分辨质谱予以确认。2. The preparation of benzofulvene-functionalized sulfoxide compounds containing different substituents (methyl, fluorine, trifluoromethyl) was achieved by a simple, mild and green method, using water as the reaction solvent without other With the addition of additives, a novel functionalized sulfoxide compound was obtained, which was confirmed by NMR and high-resolution mass spectrometry.
3.本发明原料易得、价格成本低廉,反应时间短,条件绿色、温和,产物容易分离,制备过程及工艺简单,易于操作。3. The present invention has readily available raw materials, low price and cost, short reaction time, green and mild conditions, easy separation of products, simple preparation process and process, and easy operation.
4.本发明制备的苯并富烯官能化的亚砜类化合物为药物活性分子的筛选提供原料来源,也为在药物和材料等方面的进一步转化奠定基础。4. The benzofulvene-functionalized sulfoxide compound prepared by the present invention provides a source of raw materials for the screening of pharmaceutically active molecules, and also lays a foundation for further transformation of drugs and materials.
本发明所公开的实施例只为了解释本发明的工作过程,不是对本发明技术的限定,本领域技术人员在本发明上无创造性的改变,都在本申请的保护范围内。The embodiments disclosed in the present invention are only for explaining the working process of the present invention, and are not intended to limit the technology of the present invention. Those skilled in the art have no creative changes in the present invention, which are all within the protection scope of the present application.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110909137.9A CN113461578B (en) | 2021-08-09 | 2021-08-09 | Green synthesis method of functionalized sulfoxide compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110909137.9A CN113461578B (en) | 2021-08-09 | 2021-08-09 | Green synthesis method of functionalized sulfoxide compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113461578A CN113461578A (en) | 2021-10-01 |
| CN113461578B true CN113461578B (en) | 2023-03-31 |
Family
ID=77867738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110909137.9A Active CN113461578B (en) | 2021-08-09 | 2021-08-09 | Green synthesis method of functionalized sulfoxide compound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113461578B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116693431B (en) * | 2023-05-19 | 2025-08-29 | 南华大学附属南华医院 | Clethodim sulfoxide and its synthesis method and application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106083669A (en) * | 2016-06-24 | 2016-11-09 | 湖南大学 | A kind of method being prepared β chlorine alkene sulfone compound by sulfinate and alkynes |
-
2021
- 2021-08-09 CN CN202110909137.9A patent/CN113461578B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN113461578A (en) | 2021-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113461578B (en) | Green synthesis method of functionalized sulfoxide compound | |
| CN115672296B (en) | Preparation and application of a phenylalanine-modified short-chain column [5] aromatic hydrocarbon chiral chromatography packing | |
| US9090545B2 (en) | Asymmetric synthesis of organic compounds | |
| CN110357842B (en) | A kind of fluoroalkyl substituted furan compound and its preparation method | |
| JP2001505527A (en) | Taxane derivatives having pyridyl-substituted C <13> side chains, their preparation and their use as antitumor agents | |
| CN111440166A (en) | Polysubstituted indolizine derivative and preparation method thereof | |
| CN105111244B (en) | Bicyclic [2.2.1] vinyl compound in heptan of ferrocene oxygen bridge | |
| CN110317170B (en) | Green synthesis method of 3-phenanthridinyl propyl formate compound | |
| CN113201108A (en) | (R) -CuTAPBP-COF polymer and preparation method and application thereof | |
| CN107382858B (en) | A series of 1,2,3,4-tetrahydroisoquinolin-4-one compounds and their synthetic methods and applications | |
| CN109970560B (en) | A kind of preparation method of tri-substituted 1,3 diolefin compounds | |
| CN109020989B (en) | A kind of synthetic method of trifluoromethyl-substituted 2-methyldihydrofuranochroman skeleton compound | |
| CN107513056A (en) | A kind of synthetic method of the quinolines of the group containing tetrahydrofuran | |
| CN106349249A (en) | Method for green synthesis of norcantharidin derivative | |
| CN112574056A (en) | Synthetic method of alpha, alpha-difluoro-gamma-hydroxyacetamide derivative | |
| CN111362795A (en) | Preparation method of a class of substituted butyrate derivatives | |
| CN106905336A (en) | Asymmetric synthesis method of chiral pyrazole spirofuran compound | |
| CN113429323B (en) | Preparation method of sulfonyl substituted styrene type axial chiral compound | |
| CN116162122B (en) | A dehydroepiandrosterone triazole derivative and its preparation method and application | |
| CN105017266B (en) | The chiral Tetrahydroquinolinesas of 2 aryl 1,2,3,4 and its synthetic method | |
| CN120698838A (en) | A green synthesis method for triarylmethane compounds | |
| CN115850111A (en) | Preparation method of nickel-catalyzed aliphatic amine containing gem-difluoroolefin structure | |
| CN106866488A (en) | A kind of synthetic method of the assimilation compound of 3,3 difluoro, 4 pyrrolin 2 | |
| JPWO2005085204A1 (en) | Method for producing nitrogen-containing 5-membered ring compound | |
| CN104628644A (en) | 3-azabicyclo [4,1,0] heptyl aldehydes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |